Cargando…
Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma
Esophageal adenocarcinoma (EAC) is an aggressive cancer necessitating the development of improved risk stratification tools for personalized care. Previously, microRNAs have been shown to correlate with the progression and prognosis of various cancer types; however, the value in EAC remains largely...
Autores principales: | Matsui, Daisuke, Zaidi, Ali H., Martin, Samantha A., Omstead, Ashten N., Kosovec, Juliann E., Huleihel, Luai, Saldin, Lindsey T., DiCarlo, Christina, Silverman, Jan F., Hoppo, Toshitaka, Finley, Gene G., Badylak, Stephen F., Kelly, Ronan J., Jobe, Blair A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348392/ https://www.ncbi.nlm.nih.gov/pubmed/27793030 http://dx.doi.org/10.18632/oncotarget.12832 |
Ejemplares similares
-
Intratumoral immunotherapy with STING agonist, ADU-S100, induces CD8+ T-cell mediated anti-tumor immunity in an esophageal adenocarcinoma model
por: Zaidi, Ali H., et al.
Publicado: (2021) -
High yield reproducible rat model recapitulating human Barrett’s carcinogenesis
por: Matsui, Daisuke, et al.
Publicado: (2017) -
CDK4/6 dual inhibitor abemaciclib demonstrates compelling preclinical activity against esophageal adenocarcinoma: a novel therapeutic option for a deadly disease
por: Kosovec, Juliann E., et al.
Publicado: (2017) -
MicroRNA Signature Characterizes Primary Tumors That Metastasize in an Esophageal Adenocarcinoma Rat Model
por: Zaidi, Ali H., et al.
Publicado: (2015) -
Prognostic immune markers for recurrence and survival in locally advanced esophageal adenocarcinoma
por: Babar, Laila, et al.
Publicado: (2019)